%0 Journal Article
%T 蛋白质组学在恶性胸腔积液研究中的应用现状及进展
%A 刘晓晴
%A 杨琳
%A 许晶
%J 肿瘤防治研究
%D 2015
%R 10.3971/j.issn.1000-8578.2015.03.017
%X 摘要 蛋白质组学的研究对象是生命活动的执行者——蛋白质，而恶性胸腔积液中富含蛋白质，尤其是组织特异性、肿瘤相关性的蛋白，所以通过蛋白质组学研究恶性胸腔积液对于认识其蛋白谱、找出疾病相关的生物标志物、发现病因有重要意义。本文主要从组成蛋白质组学及比较蛋白质组学两方面，对近年来蛋白质组学在恶性胸腔积液中的研究进行综述
%K 蛋白质组学
%K 恶性胸腔积液
%K 生物标志物
%K Progress of Relationships of Calprotectin with Tumours
%K Screening of Potential Proteins Associated with Carboplatin-resistance in Advanced Ovarian Serous Adenocarcinoma Tissues Using iTRAQ Technology
%K Review on Researches of TFF3 as Tumor Biomarker
%K MicroRNAs Expression in Benign and Malignant Pleural Effusion
%K Recent Progress of microRNA as Colorectal Cancer Clinical Biomarker
%K Correlation of Dynamic Changes of Candidate Plasma Proteins Expression with Development of Cervical Carcinogenesis in Uyghur Women
%K Clinical Characteristics and Prognostic Factors in Breast Cancer with Malignant Pleural Effusion
%K Research for Proteomics Discrepancies between Osteosarcoma and Normal Bone Tissue
%K Expression and Clinical Significance of microRNA-31 in Primary Lung Cancer Tumor Tissues
%K Effects of Intrathoracic DC-CIK Treatment and Chemotherapy on Immune Indexes in Malignant Pleural Effusion
%K Serum Protein Fingerprint Diagnoic Patterns was Established by MALDI-TOF MS for Human Esophagial Carcinoma
%K Role of Quantitative Proteomic Strategy by Laser Capture Microdissection Combined with Acetylation Stable Isotope Labeling in Colorectal Cancer
%K Cisplatin Combined with Interleukin-2 to Treat Malignant Pleural Effusion
%U http://www.zlfzyj.com/CN/abstract/abstract8450.shtml